Skin cancers after liver transplantation: Retrospective single-center study on 371 recipients

Transplantation

Volumn 98, Issue 3, 2014, Pages 335-340

  Ducroux, Emilie ^a   Boillot, Olivier ^a   Ocampo, Maria Andrea ^a   Decullier, Evelyne ^b,c,d   Roux, Adeline ^b   Dumortier, Jérôme ^a   Kanitakis, Jean ^a   Jullien, Denis ^a   Euvrard, Sylvie ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Basal cell carcinoma; Immunosuppression; Liver transplantation; Skin cancers; Squamous cell carcinoma

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ACTINIC KERATOSIS; ADULT; AGE; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAIR COLOR; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; VIRUS HEPATITIS;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 84905859281     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000051     Document Type: Article

References (28)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681.
2. Euvrard S, Kanitakis J. Skin cancers after liver transplantation: What to do J Hepatol 2006; 44: 27.
3. Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 2002; 8: 939.
4. Herrero JI, España A, D'Avola D, et al. Subsequent nonmelanoma skin cancer after liver transplantation. Transplant Proc 2012; 44: 1568.
5. Belloni-Fortina A, Piaserico S, Bordignon M, et al. Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol 2012; 92: 411.
6. Herrero JI, España A, Quiroga J, et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl 2005; 11: 1100.
7. Jain A, Marcos A, Reyes J, et al. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc 2005; 37: 1207.
8. Saigal S, Norris S, Muiesan P, et al. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002; 8: 482.
9. Levy M, Backman L, Husberg B, et al. De novomalignancy following liver transplantation: A single-center study. Transplant Proc 1993; 25: 1397.
10. Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit. Am J Transplant 2010; 10: 1889.
11. Krynitz B, Edgren G, Lindelöf B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-A Swedish population-based study. Int J Cancer 2013; 132: 1429.
12. Otley CC, Pittelkow MR. Skin cancer in liver transplant recipients. Liver Transpl 2000; 6: 253.
13. Jiménez-Romero C, Manrique Municio A, Marqués Medina E, et al. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases. Transplant Proc 2006; 38: 2505.
14. Watt KDS, Pedersen RA, Kremers WK, et al. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009; 137: 2010.
15. Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001; 7: 971.
16. Jensen AØ, Svaerke C, Farkas D, et al. Skin cancer risk among solid organ recipients: A nationwide cohort study in Denmark. Acta Derm Venereol 2010; 90: 474.
17. Chandok N, Watt KD. The burden of de novo malignancy in the liver transplant recipient. Liver Transpl 2012; 18: 1277.
18. Euvrard S, Claudy A. Post-transplant skin cancer: The influence of organ and pre-transplant disease. Cancer Treat Res 2009; 146: 65.
19. Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skincancer prevention in kidney transplantation. NEngl JMed 2012; 367: 329.
20. WebbMC,Compton F, Andrews PA, et al. Skin tumours posttransplantation: A retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997; 29: 828.
21. Tallón Aguilar L, Barrera Pulido L, Bernal Bellido C, et al. Causes and predisposing factors of de novo tumors in our series of liver transplant recipients. Transplant Proc 2009; 41: 2453.
22. Christiansen TN, Freije JE, Neuburg M, et al. Cutaneous squamous cell carcinoma metastatic to the parotid gland in a transplant patient. Clin Transplant 1996; 10: 561.
23. Brown VL, Matin RN, Cerio R, et al. Melanomas in renal transplant recipients: The London experience, and invitation to participate in a European study. Br J Dermatol 2007; 156: 165.
24. Le Mire L, Hollowood K, Gray D, et al. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154: 472.
25. Vajdic CM, van Leeuwen MT,Webster AC, et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev 2009; 18: 2297.
26. Casper C, Krantz EM, Corey L, et al. Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 2008; 198: 23.
27. Wisgerhof HC, Wolterbeek R, de Fijter JW, et al. Kidney transplant recipients with cutaneous squamous cell carcinoma have an increased risk of internal malignancy. J Invest Dermatol 2012; 132: 2176.
28. De Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol 2001; 19: 231.